Monday, July 13, 2020

Poseida Therapeutics Debuts In IPO

San Diego-based biopharmaceuticals firm Poseida Therapeutics successfully made it to the public markets with an IPO on Friday, raising $224M in an offering on the Nasdaq Global Select Market. The company, which now trades as PSTX, priced its IPO of 14,000,000 shares of its common stock at $16.00 on Friday on Thursday evening, an as of early Monday tradin

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.